These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 18234697)

  • 1. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series.
    Beck J; Rohrer JD; Campbell T; Isaacs A; Morrison KE; Goodall EF; Warrington EK; Stevens J; Revesz T; Holton J; Al-Sarraj S; King A; Scahill R; Warren JD; Fox NC; Rossor MN; Collinge J; Mead S
    Brain; 2008 Mar; 131(Pt 3):706-20. PubMed ID: 18234697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative.
    Rademakers R; Baker M; Gass J; Adamson J; Huey ED; Momeni P; Spina S; Coppola G; Karydas AM; Stewart H; Johnson N; Hsiung GY; Kelley B; Kuntz K; Steinbart E; Wood EM; Yu CE; Josephs K; Sorenson E; Womack KB; Weintraub S; Pickering-Brown SM; Schofield PR; Brooks WS; Van Deerlin VM; Snowden J; Clark CM; Kertesz A; Boylan K; Ghetti B; Neary D; Schellenberg GD; Beach TG; Mesulam M; Mann D; Grafman J; Mackenzie IR; Feldman H; Bird T; Petersen R; Knopman D; Boeve B; Geschwind DH; Miller B; Wszolek Z; Lippa C; Bigio EH; Dickson D; Graff-Radford N; Hutton M
    Lancet Neurol; 2007 Oct; 6(10):857-68. PubMed ID: 17826340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations.
    Pickering-Brown SM; Rollinson S; Du Plessis D; Morrison KE; Varma A; Richardson AM; Neary D; Snowden JS; Mann DM
    Brain; 2008 Mar; 131(Pt 3):721-31. PubMed ID: 18192287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia.
    Snowden JS; Pickering-Brown SM; Mackenzie IR; Richardson AM; Varma A; Neary D; Mann DM
    Brain; 2006 Nov; 129(Pt 11):3091-102. PubMed ID: 17003069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia.
    van Swieten JC; Heutink P
    Lancet Neurol; 2008 Oct; 7(10):965-74. PubMed ID: 18771956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study.
    Le Ber I; Camuzat A; Hannequin D; Pasquier F; Guedj E; Rovelet-Lecrux A; Hahn-Barma V; van der Zee J; Clot F; Bakchine S; Puel M; Ghanim M; Lacomblez L; Mikol J; Deramecourt V; Lejeune P; de la Sayette V; Belliard S; Vercelletto M; Meyrignac C; Van Broeckhoven C; Lambert JC; Verpillat P; Campion D; Habert MO; Dubois B; Brice A;
    Brain; 2008 Mar; 131(Pt 3):732-46. PubMed ID: 18245784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations.
    Rohrer JD; Ridgway GR; Modat M; Ourselin S; Mead S; Fox NC; Rossor MN; Warren JD
    Neuroimage; 2010 Nov; 53(3):1070-6. PubMed ID: 20045477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration.
    Yu CE; Bird TD; Bekris LM; Montine TJ; Leverenz JB; Steinbart E; Galloway NM; Feldman H; Woltjer R; Miller CA; Wood EM; Grossman M; McCluskey L; Clark CM; Neumann M; Danek A; Galasko DR; Arnold SE; Chen-Plotkin A; Karydas A; Miller BL; Trojanowski JQ; Lee VM; Schellenberg GD; Van Deerlin VM
    Arch Neurol; 2010 Feb; 67(2):161-70. PubMed ID: 20142524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer neuropathology without frontotemporal lobar degeneration hallmarks (TAR DNA-binding protein 43 inclusions) in missense progranulin mutation Cys139Arg.
    Redaelli V; Rossi G; Maderna E; Kovacs GG; Piccoli E; Caroppo P; Cacciatore F; Spinello S; Grisoli M; Sozzi G; Salmaggi A; Tagliavini F; Giaccone G
    Brain Pathol; 2018 Jan; 28(1):72-76. PubMed ID: 27997711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in the progranulin gene affect global gene expression in frontotemporal lobar degeneration.
    Chen-Plotkin AS; Geser F; Plotkin JB; Clark CM; Kwong LK; Yuan W; Grossman M; Van Deerlin VM; Trojanowski JQ; Lee VM
    Hum Mol Genet; 2008 May; 17(10):1349-62. PubMed ID: 18223198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The heritability and genetics of frontotemporal lobar degeneration.
    Rohrer JD; Guerreiro R; Vandrovcova J; Uphill J; Reiman D; Beck J; Isaacs AM; Authier A; Ferrari R; Fox NC; Mackenzie IR; Warren JD; de Silva R; Holton J; Revesz T; Hardy J; Mead S; Rossor MN
    Neurology; 2009 Nov; 73(18):1451-6. PubMed ID: 19884572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.
    Bieniek KF; Murray ME; Rutherford NJ; Castanedes-Casey M; DeJesus-Hernandez M; Liesinger AM; Baker MC; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2013 Feb; 125(2):289-302. PubMed ID: 23053135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin.
    Mukherjee O; Pastor P; Cairns NJ; Chakraverty S; Kauwe JS; Shears S; Behrens MI; Budde J; Hinrichs AL; Norton J; Levitch D; Taylor-Reinwald L; Gitcho M; Tu PH; Tenenholz Grinberg L; Liscic RM; Armendariz J; Morris JC; Goate AM
    Ann Neurol; 2006 Sep; 60(3):314-22. PubMed ID: 16983685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration.
    Gass J; Cannon A; Mackenzie IR; Boeve B; Baker M; Adamson J; Crook R; Melquist S; Kuntz K; Petersen R; Josephs K; Pickering-Brown SM; Graff-Radford N; Uitti R; Dickson D; Wszolek Z; Gonzalez J; Beach TG; Bigio E; Johnson N; Weintraub S; Mesulam M; White CL; Woodruff B; Caselli R; Hsiung GY; Feldman H; Knopman D; Hutton M; Rademakers R
    Hum Mol Genet; 2006 Oct; 15(20):2988-3001. PubMed ID: 16950801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity within a large kindred with frontotemporal dementia: a novel progranulin mutation.
    Bruni AC; Momeni P; Bernardi L; Tomaino C; Frangipane F; Elder J; Kawarai T; Sato C; Pradella S; Wakutani Y; Anfossi M; Gallo M; Geracitano S; Costanzo A; Smirne N; Curcio SA; Mirabelli M; Puccio G; Colao R; Maletta RG; Kertesz A; St George-Hyslop P; Hardy J; Rogaeva E
    Neurology; 2007 Jul; 69(2):140-7. PubMed ID: 17620546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pathogenic progranulin mutation and C9orf72 repeat expansion in a family with frontotemporal dementia.
    Lashley T; Rohrer JD; Mahoney C; Gordon E; Beck J; Mead S; Warren J; Rossor M; Revesz T
    Neuropathol Appl Neurobiol; 2014 Jun; 40(4):502-13. PubMed ID: 24286341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The unexpected co-occurrence of GRN and MAPT p.A152T in Basque families: Clinical and pathological characteristics.
    Moreno F; Indakoetxea B; Barandiaran M; Caballero MC; Gorostidi A; Calafell F; Gabilondo A; Tainta M; Zulaica M; Martí Massó JF; López de Munain A; Sánchez-Juan P; Lee SE
    PLoS One; 2017; 12(6):e0178093. PubMed ID: 28594853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations.
    Van Deerlin VM; Wood EM; Moore P; Yuan W; Forman MS; Clark CM; Neumann M; Kwong LK; Trojanowski JQ; Lee VM; Grossman M
    Arch Neurol; 2007 Aug; 64(8):1148-53. PubMed ID: 17698705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Loss-of-Function GRN Mutation p.(Tyr229*): Clinical and Neuropathological Features.
    Kuuluvainen L; Pöyhönen M; Pasanen P; Siitonen M; Rummukainen J; Tienari PJ; Paetau A; Myllykangas L
    J Alzheimers Dis; 2017; 55(3):1167-1174. PubMed ID: 27767988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progranulin-associated PiB-negative logopenic primary progressive aphasia.
    Josephs KA; Duffy JR; Strand EA; Machulda MM; Vemuri P; Senjem ML; Perkerson RB; Baker MC; Lowe V; Jack CR; Rademakers R; Whitwell JL
    J Neurol; 2014 Mar; 261(3):604-14. PubMed ID: 24449064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.